Authors Rubic3n
Matrix M coating for cancer therapeutics
Following in the orchestrated wave if 'Emerging infectious diseases'.
A good cloak to hide a nasty machinery beneath.
2022
https://t.co/gm76Pzw0KT
further articles in following tweet
2017 Biomerieux
https://t.co/hrCU2xVi3U
2016
https://t.co/ZpyQ4WeUWZ
2016
https://t.co/ua10Y0fu0Z
2015 mice
2017
Pushing the
CEPI Dialogue
Excellent presentation to see, how they, including Bancel, had layed out the narrative.
Quess, what they had specifically included in their list of targeted viruses?
https://t.co/J5FDe6W986

Fondation Merieux 2017
CEPI
Almost basking about their list being more inclusive, more emergent viruses based.
https://t.co/J5FDe6W986

Fondation Merieux 2017
Narrative: "Look, what ZIKA has done to your populace. Nasty ZIKA."
How much of that ZIKA damage was actually related to a virus? Was there a computer guy, who had invested in mosquitos as a vector?
https://t.co/J5FDe6W986

Fondation Merieux 2017
What is the advanges of a programme like CEPI.
And for who?
Let me translate: They want a coordinated vaccine production, with only one strong production pipeline, and solidly regulated pathsways.
Provide the incentives for big pharma.
They've made it.

Vision - look at nasty ZIKA, you surely do not want that
Mission - get the pipeline going of (only) the big ones
Scope - the anti-cancer platforms with their DNA, mRNA basis fit perfectly. They so far do not sell very well, but they could be recycled.
Correct me, if I am wrong.

Nachfolgend
- zum Bau des Labors in Wuhan durch BioMerieux -> Bancel jetzt Moderna
- Werbebroschüre BioMerieux (CEPI GAVI Einbindung)
- Moderna ominöser geheimer weiterer Impfstoff
1
Bau des Labors in Wuhan BioMerieux Beteiligung
2004
CCP
— rubic3n (@rubic3n) February 19, 2021
US
France
all in.
Gates Biontech, Biomerieux Moderna, Gilead Trump
All in.
Who is more?@franciscodeasis https://t.co/ADowRaYHsL
Bancel BioMerieux
However, through the Bancel (WEF), James Le Duc, Biomerieux gateway France still stayed pretty well in the game - however, sophisticatedly covered. Quite a camouflage masterpiece.
— rubic3n (@rubic3n) August 29, 2021
This is where 100Mio EU funding went?https://t.co/hFvdBS62rYhttps://t.co/jkJgyBdiYk pic.twitter.com/rulfKhKIWw
Mehr zum Bau des Labors durch BioMerieus in Wuhan (Stephane Bancel ex BioMerieux jetzt
biomerieux has the lab in lyon and they also made the lab in wuhan. https://t.co/dmgTLZ1kEK
— Bianca, fight the abolition of human rights (@Bianca50406170) November 16, 2021
Bancel BioMerieux Wuhan
I\u2019m wondering if/when this will catch on... https://t.co/PoBxz4JyiW pic.twitter.com/1rZFot4uxr
— Jesse \u201cEpstein+WEF+\U0001f1fa\U0001f1f3=Malthusianism\U0001f489\u201d Matchey (@JesseMatchey) January 9, 2022
An 80% market for mRNA. Yet, the vector is the bottleneck causing the limitation.
Viral V is almost a 'use once only' bcs of antibody formation.
LNP sole way to push.
READ THE INTRODUCTION... https://t.co/1k4qZeutit
— Not Your Mom (@Notyour28981739) December 24, 2021
mRNA Therapy - with a gargantuan market - in dire need for a vector.
Viral vectors as a dead ally until 2015.
mRNA Therapy meets enormous resentments.
Luckily, billions of people have now got first hand experience. Obviously, AZ was not that useful in the general drift.

LNP instead of a vector
PFIZER BioNtech
ALC-0315
ALC-0159, DSPC
"This product is for research use only and not for human use."
https://t.co/tNsG5wxVCT
'EMA Zulassung ohne
https://t.co/rSOxRFTZwHhttps://t.co/gi40e7mUqIhttps://t.co/3yAElKnXgshttps://t.co/QXYZbFxHRqhttps://t.co/Nb0q026Zvj
— Lexa W. \U0001f1e9\U0001f1ea (@rebew_lexa) December 22, 2021
Official statement by Echelon
Paraphrased - "we do produce it, but only for use in labs.
Pfizer get theirs from other companies. With them it is safe in humans."
No study data presented
A reference to GMP as 'safe in humans'
ALC-0315
ALC-0159, DSPC

PFIZER LNP
This paper claims "It is just like another fatty compound. You eat salad oil and chips as well"
https://t.co/uncdUpkFnI
No, it is not.